FDA
-
-
-
-
-
-
-
Citius Oncology Expands International Distribution of LYMPHIRâ„¢ to European Union Through Exclusive Agreement with Uniphar
-
-
-
-
-
-
-
Citius Oncology Announces $18 Million Concurrent Registered Direct Offering and Private Placement Priced At-The-Market Under Nasdaq Rules
-
-
-
-
-
-
-
Citius Oncology partners with Verix AI for LYMPHIR launch
-
-
-
-
-
-
-
Citius Oncology Signs U.S. Distribution Agreement with McKesson to Support LYMPHIRâ„¢ Commercial Launch
-
-
-
-
-
-
-
Citius Oncology Announces Closing of $9.0 Million Registered Direct Offering and Concurrent Private Placement
-
-
-
-
-
-
-
Citius Oncology closes $9 million public offering
-
-
-
-
-
-
-
Citius Pharmaceuticals regains Nasdaq compliance
-
312,667 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All

